Biologics Spine Top Stories FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO byChris StewartJanuary 4, 2023
Spine FzioMed Enrolls Patient Number Fifty in Clinical Study to Support the Effectiveness and Safety of Oxiplex® for the Reduction of Pain and Symptoms Following Lumbar Surgery byJosh SandbergMarch 29, 2019
Biologics FzioMed Announces 500,000 Units of Oxiplex® Shipped Worldwide byJosh SandbergJanuary 11, 2018
Hospitals FzioMed Receives FDA Approval for Small Confirmatory Study of Oxiplex® in Patients Undergoing Lumbar Surgery for Disc Herniation byJosh SandbergOctober 24, 2017
